A team of researchers from the University of Miami Miller School of Medicine has shown that the I-Portal Neuro Otologic Test, which uses the head-mounted goggle that gauges eye movement through video cameras and computers, can successfully diagnose concussion with 95 percent specificity and 89 percent sensitivity.
A first-of-its-kind trial using stem cells in Alzheimer’s disease patients that is led by UHealth -- the University of Miami Health System and sponsored by Miami-based life sciences company Longeveron LLC, has received a $1 million award from the Alzheimer’s Association.
Beginning in October, South Florida’s only academic medical system, UHealth — the University of Miami Health System, will take a major step in expanding the way its pioneering research touches the lives of patients. With the launch of the UHealth Consent-To-Contact Initiative, patients will have a unique opportunity to take advantage of the many innovative therapies and treatments available through the health system.
When Marilyn K. Glassberg, M.D., professor of medicine, surgery and pediatrics, spoke at an international conference held at the Vatican, she delivered a moving account of the promising early results obtained by investigators at the University of Miami Miller School of Medicine in a small clinical trial that explored stem cell treatment in patients with idiopathic pulmonary fibrosis (IPF).
Perfect Synergy between Sylvester Researchers Leads to $1.15 Million DOD Idea Development Award 09.20.2016
Sylvester Comprehensive Cancer Center and University of Miami Miller School of Medicine researchers Priyamvada Rai, Ph.D., associate professor of medicine/hematology and oncology, and Kerry Burnstein, Ph.D., professor of molecular and cellular pharmacology, have received a $1.15 million Idea Development Award from the Department of Defense (DOD) to investigate a novel mechanism of inhibiting incurable prostate cancer.
Ongoing Study Improves Predictions of Which Chiari Malformation Patients Will Benefit from Surgery 09.20.2016
A research team led by Noam Alperin, Ph.D., professor of radiology and biomedical engineering, and Director of the Physiologic Imaging and Modeling Lab, has continued to refine the means of determining which patients with a neurological disorder known as Chiari Malformation Type I (CMI) will benefit from surgery.
Miller School Researchers to Collaborate in Study of Inflammatory Bowel Disease in Hispanics 09.20.2016
A team of Miller School of Medicine researchers has been awarded a $1.26 million grant to explore genetic variation in U.S.-born and foreign-born Hispanic patients with inflammatory bowel disease (IBD). The project will build upon the existing interdisciplinary IBD clinical and genomics research collaborative at the Miller School.
Dr. Sara J. Czaja Elected to the Executive Council of the Human Factors and Ergonomics Society 09.20.2016
Sara J. Czaja, Ph.D., Leonard M. Miller Professor of Psychiatry and Behavioral Sciences and Director of the Center on Aging at the University of Miami Miller School of Medicine, has been elected to a four-year term on the Executive Council of the Human Factors and Ergonomics Society.
A team of University of Miami Miller School of Medicine investigators has been awarded a three-year $2 million grant from the National Institutes of Health to study biological treatments for blindness — specifically factors that affect neural regeneration in the retina. The Miller School team was one of only six nationwide to receive funding.
For the seventh consecutive year, the University of Miami Miller School of Medicine and the Department of Psychiatry and Behavioral Sciences will support the American Foundation for Suicide Prevention at their annual Out of the Darkness Community Walk. The event is an effort to reach people with mental illnesses and those impacted by suicide.